Canada · Series A startup

Who invested in Vital Bio

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Martech

Funding summaryUpdated 26 Oct 2026

$18Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $18MJul 2023
Investors
5
See who backed them

The rounds

  1. Jul 2023

Everyone who backed them

FJ LabsVC firm1round
8VCVC firm1round
Inovia CapitalVC firm1round
Abstract VenturesVC firm1round
Quiet CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 7 firms list Vital Bio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Alpha Wave GlobalPrivate equityPer its own site
MBX CapitalVC firmPer its own site
Garage CapitalVC firmPer its own site
1955 CapitalVC firmPer its own site
McNamara Family InvestmentsFamily officePer its own site
NEXT VENTŪRESVC firmPer its own site
Rhythm VCVC firmPer its own site

Quick answers about Vital Bio

Who invested in Vital Bio?

Vital Bio's investors include FJ Labs, 8VC, Inovia Capital, Abstract Ventures and Quiet Capital.

How much has Vital Bio raised?

Vital Bio has raised $18M across 1 round since 2023.

When did Vital Bio last raise?

Vital Bio's most recent round was a Series A of $18M in Jul 2023.

What was Vital Bio's biggest round?

Its most recent round, $18M in Jul 2023, is also its largest on record.

Who backed Vital Bio first?

Vital Bio's first round on record, in Jul 2023, was backed by FJ Labs, 8VC and Inovia Capital and 2 others.

What stage is Vital Bio at?

Vital Bio's latest named round is a Series A, in Jul 2023.

Where is Vital Bio based?

Vital Bio is based in Canada.

Companies like Vital Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.